Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

Royal Adelaide Hospital

Adelaide, South Australia

Magenta Marker Royal Adelaide Hospital

North Terrace
Adelaide SA 5000
+61 8 8222 4000
www.rah.sa.gov.au

Our Collaborators

Andrew Ruszkiewic

Staff Specialist Pathologist, Department of Anatomical Pathology

Chris Worthley

Consultant Surgeon, Department of Surgery

John Chen

Consultant Surgeon, Department of Surgery

Mark Brooke-Smith

Consultant Surgeon, Department of Surgery

Nam Nguyen
Consultant Gastroenterologist, Department of Gastroenterology

Virginia Papangelis

Tumour Bank Coordinator

Tamara Debrencini

Research Assistant

-34.9206792 138.609493

North Terrace
Adelaide SA 5000
+61 8 8222 4000
www.rah.sa.gov.au

Our Collaborators

Andrew Ruszkiewic

Staff Specialist Pathologist, Department of Anatomical Pathology

Chris Worthley

Consultant Surgeon, Department of Surgery

John Chen

Consultant Surgeon, Department of Surgery

Mark Brooke-Smith

Consultant Surgeon, Department of Surgery

Nam Nguyen
Consultant Gastroenterologist, Department of Gastroenterology

Virginia Papangelis

Tumour Bank Coordinator

Tamara Debrencini

Research Assistant